J Kevin Buchi Dicerna Pharmaceuticals Inc (DRNA) insider trading activity

DRNA Quotes by TradingView

J Kevin Buchi is Director of Dicerna Pharmaceuticals Inc. Currently has a direct ownership of 0 shares of DRNA, which is worth approximately $0. The most recent transaction as insider was on Dec 28, 2021, when has been sold 4,666 shares (Common Stock) at a price of $38.25 per share, resulting in proceeds of $178,474. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

J KEVIN BUCHI Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 28 2021
SELL
Disposition due to a tender of shares in a change of control transaction
$178,474 $38.25 p/Share
4,666 Reduced 100.0%
0 Common Stock
Jun 03 2021
BUY
Exercise of conversion of derivative security
-
4,666 Added 50.0%
4,666 Common Stock

Also insider at

AMRX
Amneal Pharmaceuticals, Inc. Healthcare
Director
AMPE
Ampio Pharmaceuticals, Inc. Healthcare
Director
BNTC
Benitec Biopharma Inc. Healthcare
Director
TCRT
Alaunos Therapeutics, Inc. Healthcare
Director
JKB

J Kevin Buchi

Director
Boston, MA

Track Institutional and Insider Activities on DRNA

Follow Dicerna Pharmaceuticals Inc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DRNA shares.

Notify only if

Insider Trading

Get notified when an Dicerna Pharmaceuticals Inc insider buys or sells DRNA shares.

Notify only if

News

Receive news related to Dicerna Pharmaceuticals Inc

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on DRNA